Hofseth Biocare ASA banner

Intrinsic Value

The intrinsic value of Hofseth Biocare ASA (HBQ) under the Base Case is 0.2068 EUR per share. Compared with the current market price of 0.0794 EUR, the stock appears Undervalued by 62% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

HBQ Intrinsic Value
€0.2068
Undervaluation 62%
Intrinsic Value
Price €0.0794

HBQ is cheaper than usual. It was this cheap or cheaper on less than 1% of days in the past 5 years.

Monitor HBQ
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €0.17
Get notified when the price drops into your buy zone
Intrinsic Value €0.21
Margin of Safety 20% €0.17
Current Price €0.08
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to HBQ

Fundamental Analysis

What Hofseth Biocare ASA Does

Biotechnology Health Care

Hofseth Biocare ASA is a Norwegian life-sciences company that turns salmon side streams into specialty ingredients. It processes fish raw material into products such as fish oils, protein hydrolysates, and calcium-rich ingredients that can be used in nutrition and health-focused products. In simple terms, it takes material that would otherwise be low-value by-product and upgrades it into higher-value ingredients.

Headquarters
Norway NO
Employees
81
IPO date
Dec 2, 2011
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Hofseth Biocare ASA

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one HBQ stock?

The intrinsic value for Hofseth Biocare ASA (HBQ) under the Base Case is 0.2068 EUR.

Is HBQ stock undervalued or overvalued?

Compared with the current market price of 0.0794 EUR, the stock appears Undervalued by 62% .

Back to Top